Search

everythinglearnresearchcommunity

for

Search:↓

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

Different forms of FGF5 either promote or inhibit hair growth.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

Granulation tissue-derived cells can aid wound healing and serve as an alternative source of stem cells for tissue repair.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

Epiregulin can help hair grow and may be useful for treating hair loss.

IGF-1, KGF, and stem cells help skin cells move and survive, potentially speeding up wound healing.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

FGF-9 speeds up the early development of certain organs, showing potential for organ regeneration.

Meis1 is crucial for skin health and tumor development.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

PDGFA/AKT signaling is important for the growth and maintenance of certain skin fat cells.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

Lower SMAD2/3 activation predicts more severe skin cancer.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

Compound 6 is a promising candidate for better wound healing.